Joseph Cencetti, PharmD, BCACP, CLS

Article

Safety and Efficacy of Ezetimibe in Patients With and Without Chronic Kidney Disease at a Pharmacist-Managed Clinic

Author:: Joseph Cencetti, PharmD, BCACP, CLS

Publish date: May 9, 2025

Statins are widely used to reduce lowdensity lipoprotein (LDL) and nonhigh-density lipoprotein (HDL) levels for the prevention of atherosclerotic c...

Article

Reducing or Discontinuing Insulin or Sulfonylurea When Initiating a Glucagon-like Peptide-1 Agonist

Author:: Joseph Cencetti, PharmD, BCACP, CLS

Publish date: February 1, 2024

This study sought to determine whether patients taking a glucagon-like peptide-1 agonist in combination with insulin and/or a sulfonylurea for type...

Article

Muscle-Related Adverse Events Associated With PCSK9 Inhibitors in a Veteran Population

Author:: Joseph Cencetti, PharmD, BCACP, CLS

Publish date: February 9, 2023

Statins and PCSK9 inhibitors (PCSK9i) are used to lower low-density lipoprotein cholesterol and reduce cardiovascular events, yet some patients are...